Camelia Dumitras

432 total citations
10 papers, 221 citations indexed

About

Camelia Dumitras is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Camelia Dumitras has authored 10 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Camelia Dumitras's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (6 papers) and vaccines and immunoinformatics approaches (2 papers). Camelia Dumitras is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (6 papers) and vaccines and immunoinformatics approaches (2 papers). Camelia Dumitras collaborates with scholars based in United States, Belgium and United Kingdom. Camelia Dumitras's co-authors include Raymond J. Lim, Kostyantyn Krysan, Steven M. Dubinett, Linh M. Tran, Ramin Salehi‐Rad, Stephanie L. Ong, Rui Li, David B. Shackelford, Bin Liu and Stacy J. Park and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Camelia Dumitras

10 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camelia Dumitras United States 7 123 104 84 54 41 10 221
Łukasz Galus Poland 12 141 1.1× 91 0.9× 127 1.5× 25 0.5× 44 1.1× 34 259
Mathieu Larroquette France 6 131 1.1× 95 0.9× 95 1.1× 90 1.7× 45 1.1× 12 239
Wenxiao Dai China 6 126 1.0× 115 1.1× 75 0.9× 37 0.7× 30 0.7× 7 270
Joseph Tintelnot Germany 9 131 1.1× 57 0.5× 73 0.9× 58 1.1× 28 0.7× 18 220
Silvia Carnevale Italy 7 78 0.6× 142 1.4× 50 0.6× 15 0.3× 15 0.4× 7 197
Soren Charmsaz United States 8 103 0.8× 61 0.6× 73 0.9× 24 0.4× 40 1.0× 15 184
Umberto Rosato United States 4 106 0.9× 112 1.1× 115 1.4× 18 0.3× 26 0.6× 4 258
Marit J van Elsas Netherlands 7 129 1.0× 164 1.6× 54 0.6× 19 0.4× 15 0.4× 8 236
Fernando Henao Spain 7 121 1.0× 67 0.6× 37 0.4× 50 0.9× 31 0.8× 24 198
Eva Hulstaert Belgium 8 74 0.6× 48 0.5× 118 1.4× 20 0.4× 96 2.3× 20 251

Countries citing papers authored by Camelia Dumitras

Since Specialization
Citations

This map shows the geographic impact of Camelia Dumitras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camelia Dumitras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camelia Dumitras more than expected).

Fields of papers citing papers by Camelia Dumitras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camelia Dumitras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camelia Dumitras. The network helps show where Camelia Dumitras may publish in the future.

Co-authorship network of co-authors of Camelia Dumitras

This figure shows the co-authorship network connecting the top 25 collaborators of Camelia Dumitras. A scholar is included among the top collaborators of Camelia Dumitras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camelia Dumitras. Camelia Dumitras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Oh, Michael S., Camelia Dumitras, Ramin Salehi‐Rad, et al.. (2024). Characteristics of a CCL21 Gene–Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 24(2). 286–298. 6 indexed citations
2.
Lim, Raymond J., Ramin Salehi‐Rad, Linh M. Tran, et al.. (2024). CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer. Cell Reports Medicine. 5(4). 101479–101479. 46 indexed citations
3.
Liu, Sixue, Shirley H. Lomeli, Yan Wang, et al.. (2023). Multi-organ landscape of therapy-resistant melanoma. Nature Medicine. 29(5). 1123–1134. 20 indexed citations
4.
Hu, Junhui, Ping Tan, Nicholas Bayley, et al.. (2023). Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma. Signal Transduction and Targeted Therapy. 8(1). 155–155. 40 indexed citations
5.
Lim, Raymond J., Ramin Salehi‐Rad, Linh M. Tran, et al.. (2022). Abstract 4208: In situ vaccination of non-small cell lung cancer with CXCL9/10-engineered dendritic cells combined with PD-1 blockade. Cancer Research. 82(12_Supplement). 4208–4208. 1 indexed citations
6.
Li, Rui, Ramin Salehi‐Rad, Milica Momcilovic, et al.. (2021). Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer. Cancer Research. 81(12). 3295–3308. 64 indexed citations
7.
Tran, Linh M., Raymond J. Lim, Camelia Dumitras, et al.. (2021). Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer. Cancers. 13(14). 3595–3595. 5 indexed citations
8.
Liu, Sixue, Hannah M. Knochelmann, Shirley H. Lomeli, et al.. (2021). Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma. Cell Reports Medicine. 2(10). 100411–100411. 31 indexed citations
9.
Lisberg, Aaron, Bin Liu, Ramin Salehi‐Rad, et al.. (2021). Phase I trial of in situ vaccination with autologous CCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC.. Journal of Clinical Oncology. 39(15_suppl). TPS9135–TPS9135. 2 indexed citations
10.
Schwab, K., Sepehr Hamidi, Raymond J. Lim, et al.. (2020). Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy. Open Forum Infectious Diseases. 7(11). ofaa424–ofaa424. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Łukasz Galus Breakdown of academic impact, for papers by Mathieu Larroquette Breakdown of academic impact, for papers by Wenxiao Dai Breakdown of academic impact, for papers by Joseph Tintelnot Breakdown of academic impact, for papers by Silvia Carnevale Breakdown of academic impact, for papers by Soren Charmsaz Breakdown of academic impact, for papers by Umberto Rosato Breakdown of academic impact, for papers by Marit J van Elsas Breakdown of academic impact, for papers by Fernando Henao Breakdown of academic impact, for papers by Eva Hulstaert
Rankless by CCL
2026